Olopatadine Hcl 0.1% Ophthalmic Solution
Sector: Hospital • Location: Ontario, Canada
Source: SAM.gov
Modification SPE2D223D0007 P00008 to exercise Option Year 3 effective February 15, 2026 through February 14, 2027. Modification SPE2D223D0007 P00007 is modified in accordance with DoD Class Deviation 2025-O0003. Modification SPE2D223D0007 P00006 to exercise Option Year 2 effective February 15, 2025 through February 14, 2026. Modification SPE2D223D0007 P00005 to incorporate FAR 52.204-30 Federal Ac
- Status
- Closed
- Sector
- Hospital, Residential, Warehouse, Manufacturing (Industrial), Aerospace & Defense, Seaport, Commercial
- Location
- Ontario, Canada
- Updated
- 3 Nov 2026
- Source
- SAM.gov
ConstructChat
Ask ConstructChat about Olopatadine Hcl 0.1% Ophthalmic Solution
Pick a question to edit it, or write your own.
First answer free · no account
Tender Information FAQ
Tender Information
Participants
| Not available for this record. |
Status
Original status | award notice |
Taiyo status | Closed |
Taiyo last update | 2026-11-03 |
Contact
| Not available for this record. |
Description
Description | Modification SPE2D223D0007 P00008 to exercise Option Year 3 effective February 15, 2026 through February 14, 2027. Modification SPE2D223D0007 P00007 is modified in accordance with DoD Class Deviation 2025-O0003. Modification SPE2D223D0007 P00006 to exercise Option Year 2 effective February 15, 2025 through February 14, 2026. Modification SPE2D223D0007 P00005 to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders language into solicitation for subject contract. Modification SPE2D223D0007 P00004 to exercise Option Year 1 effective February 15, 2024 through February 14, 2025. Modification SPE2D223D0007 P00003 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. Modification SPE2D223D0007 P00002 to incorporate clause FAR 52.204-27 Prohibition on a ByteDance Covered Application (JUN 2023) into subject contract. Modification P00001 SPE2D2-23-D-0007 revising the the price effective date and ship date from April 16, 2023 to February 28, 2023. Contract Award for Olopatadine HCL 0.1% Opthtalmic Solution 5ML Bottle |
Original sector | Not Identified |
Budget |
Location
Country | Canada |
State | Canada |
City | Ontario |
Source
Source | SAM.gov |
URL |
More Details
Record type | Tender |
Sector | Hospital, Residential, Warehouse, Manufacturing (Industrial), Aerospace & Defense, Seaport, Commercial |
Article published date | 2026-01-28 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this tender
- News and media coverage
- Technical research
Free account · no card · lands you back on this tender
More Hospital tenders in Canada
- Fluoroscopy machine with general x-ray (Medical supplies and equipment and pharmaceutical products)
- Consumables used for retinal surgeries (Medical supplies and equipment and pharmaceuticals)
- ONCOLOGY PRODUCTS (Medical supplies and equipment and pharmaceuticals)
- Supply of first aid equipment (Medical supplies and equipment and pharmaceutical products)
- Examination table with manual adjustment (lot 1) and electrical adjustment (lot 2) (Medical supplies and equipment and pharmaceutical products)
- Acquisitions of immunohistochemistry antibody clones (Medical supplies and equipment and pharmaceutical products)
- Olopatadine Hcl 0.1% Ophthalmic Solution
- Mission Canada Medical, Life, And Disability Insurance